Literature DB >> 7876919

Uptake of dietary coenzyme Q supplement is limited in rats.

Y Zhang1, F Aberg, E L Appelkvist, G Dallner, L Ernster.   

Abstract

Coenzyme Q is an important mitochondrial redox component and the only endogenously produced lipid-soluble antioxidant. Its tissue concentration decreases with aging and in a number of diseases; dietary supplementation of this lipid would fulfill important functions by counteracting coenzyme Q depletion. To investigate possible uptake, rats were administered 12 mumol coenzyme Q10/100 g body wt once daily by gastric intubation. The appearance of coenzyme Q10 in various tissues and blood after 6 h, 4 d or 8 d was studied. The control group of rats received rapeseed-soybean oil (the vehicle in the experimental group). Lipids were extracted with petroleum ethermethanol, and the reduced and oxidized forms of coenzyme Q9 and Q10 were separated and quantified by reversed-phase HPLC. In the plasma, the total coenzyme Q concentration was doubled after 4 d of treatment. Coenzyme Q10 was also recovered in liver homogenates, where, as in the plasma, it was largely in the reduced form. Uptake into the spleen could be to a large extent accounted for by the blood content of this organ. No dietary coenzyme Q10 was recovered in the heart or kidney. The uptake in the whole body was 2-3% of the total dose. Coenzyme Q10 found in the liver was located mainly in the lysosomes. Dietary coenzyme Q10 did not influence the endogenous biosynthesis of coenzyme Q9. This is in contrast to dietary cholesterol, which down-regulates cholesterol biosynthesis. The dietary coenzyme Q10 level in the plasma decreased to approximately 50% after 4 d. These results suggest that dietary coenzyme Q10 may play a role primarily in the blood and that no appreciable uptake occurs into tissues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7876919     DOI: 10.1093/jn/125.3.446

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  44 in total

1.  Evidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington's disease.

Authors:  Miriam A Hickey; Chunni Zhu; Vera Medvedeva; Nicholas R Franich; Michael S Levine; Marie-Françoise Chesselet
Journal:  Mol Cell Neurosci       Date:  2011-10-20       Impact factor: 4.314

2.  Oral repeated-dose toxicity studies of coenzyme Q10 in beagle dogs.

Authors:  Padmaja Yerramilli-Rao; M Flint Beal; Dai Watanabe; Karl Kieburtz; Elisabeth A de Blieck; Mitsuaki Kitano; Kazunori Hosoe; Iwao Funahashi; Merit E Cudkowicz
Journal:  Int J Toxicol       Date:  2012-01-20       Impact factor: 2.032

3.  Mitochondrial CoQ deficiency is a common driver of mitochondrial oxidants and insulin resistance.

Authors:  Roland Stocker; David E James; Daniel J Fazakerley; Rima Chaudhuri; Pengyi Yang; Ghassan J Maghzal; Kristen C Thomas; James R Krycer; Sean J Humphrey; Benjamin L Parker; Kelsey H Fisher-Wellman; Christopher C Meoli; Nolan J Hoffman; Ciana Diskin; James G Burchfield; Mark J Cowley; Warren Kaplan; Zora Modrusan; Ganesh Kolumam; Jean Yh Yang; Daniel L Chen; Dorit Samocha-Bonet; Jerry R Greenfield; Kyle L Hoehn
Journal:  Elife       Date:  2018-02-06       Impact factor: 8.140

4.  Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects.

Authors:  R T Matthews; L Yang; S Browne; M Baik; M F Beal
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

5.  Prophylactic role of Enhydra fluctuans against arsenic-induced hepatotoxicity via anti-apoptotic and antioxidant mechanisms.

Authors:  Tarun K Dua; Saikat Dewanjee; Ritu Khanra
Journal:  Redox Rep       Date:  2016-03-10       Impact factor: 4.412

6.  Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease.

Authors:  Marianna Sikorska; Patricia Lanthier; Harvey Miller; Melissa Beyers; Caroline Sodja; Bogdan Zurakowski; Sandhya Gangaraju; Siyaram Pandey; Jagdeep K Sandhu
Journal:  Neurobiol Aging       Date:  2014-04-02       Impact factor: 4.673

7.  Analysis of ubiquinone and tocopherol levels in normal and hyperlipidemic human plasma.

Authors:  Y Zhang; M Eriksson; G Dallner; E L Appelkvist
Journal:  Lipids       Date:  1998-08       Impact factor: 1.880

8.  Beneficial effects of a Q-ter based nutritional mixture on functional performance, mitochondrial function, and oxidative stress in rats.

Authors:  Jinze Xu; Arnold Y Seo; Darya A Vorobyeva; Christy S Carter; Stephen D Anton; Angela M S Lezza; Christiaan Leeuwenburgh
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

9.  Consumption of pasteurized human lysozyme transgenic goats' milk alters serum metabolite profile in young pigs.

Authors:  Dottie R Brundige; Elizabeth A Maga; Kirk C Klasing; James D Murray
Journal:  Transgenic Res       Date:  2009-10-22       Impact factor: 2.788

10.  Protection by Exogenously Added Coenzyme Q(9) against Free Radical-Induced Injuries in Human Liver Cells.

Authors:  Chiaki Kusumoto; Tomoyo Kinugawa; Hitoshi Morikawa; Mari Teraoka; Tadashi Nishida; Yoshikazu Murawaki; Kazuo Yamada; Tatsuya Matsura
Journal:  J Clin Biochem Nutr       Date:  2010-04-10       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.